fda drug shortages semaglutide injection status resolved 2025 Ozempic and Wegovy officially moved off FDA's shortage list FDA says that the GLP-1

However, two daily oral tablet versions have been approved by the FDA this year

To resolve these problems, Novo Nordisk won the ministry's approval for Korea-customized clinical trials in October 2021 and has been conducting them

Retatrutide has not been studied in lactating women, and the mechanism of action raises concerns about potential transfer to breast milk and effects on infant development

In select locations, dedicated product displays highlight items that can help manage common issues such as nausea and gastrointestinal discomfort, as well as products that support hydration, protein intake and overall nutrition